Results

• All
• Video
• Audio
• Images

• Most recent

1–1 of 1 result for oral therapy

• 

  Masked Safety Data from ZETA-1, an Ongoing 24-Week Phase 2 Clinical Trial of APX3330, an Oral Therapeutic Being Developed for the Treatment of Diabetic Retinopathy

  Michael J Allingham, MD, PhD

  Annual Meeting Talks

  2022